Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis

Condition:   Atopic Dermatitis Interventions:   Drug: dupilumab SAR231893;   Drug: placebo;   Drug: Emollient (moisturizer) Sponsors:   Sanofi;   Regeneron Pharmaceuticals Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials